Global public health care requires effective disease management improvements and strategies to achieve healthier populations. In parallel, scientific advancements through translational and clinical research outcomes increasingly provide opportunities at pace for improved diagnostics and precision medicine to achieve tailor-made health care solutions.

The Medical Affairs (MA) role has evolved in recent decades from an internally focused support function to become a strategically important function with a widened external lens keeping the customer- and patient-centric scope through “Outside-In” perspectives.

The MA function most likely continues to play an increasingly strategic role together with colleagues within R&D and Commercial/Marketing functions to achieve the optimal science-driven dialogue and thereby ensure the alignment of common goals to improve patient outcomes.